LIFECORE BIOMEDICAL, INC. Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests
LIFECORE BIOMEDICAL, INC. (LFCR) had Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests of $50.19 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Including Noncontrolling Interest
us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests · last filed 2026-08-05
- 2026-06-30: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $50.19M.
- 2026-03-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $49.22M.
- 2025-12-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $48.26M.
- 2025-09-30: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $47.32M.
| Period end | Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests | Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests as first filed |
|---|---|---|
| 2026-06-30 | $50.19M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $49.22M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $48.26M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $47.32M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $46.40M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $46.10M 10-Q · filed 2026-08-05 | |
| 2025-02-23 | $45.20M 10-Q · filed 2026-08-05 | |
| 2024-11-24 | $44.31M 10-Q · filed 2026-08-05 | $44.31M 10-Q · filed 2025-01-02 |
| 2024-08-25 | $43.44M 10-Q · filed 2025-11-06 | |
| 2024-05-26 | $42.59M 10-KT · filed 2026-03-16 | |
| 2024-02-25 | $41.75M 10-Q · filed 2025-04-03 | |
| 2023-11-26 | $40.92M 10-Q · filed 2025-04-03 | |
| 2023-08-27 | $40.11M 10-Q · filed 2025-01-02 | |
| 2023-05-28 | $39.32M 10-KT · filed 2026-03-16 | |
| 2023-02-26 | $38.53M 10-Q · filed 2024-08-09 | $38.51M 10-Q · filed 2023-06-02 |
| 2022-11-27 | $0.00 10-Q · filed 2024-08-09 | |
| 2022-08-28 | $0.00 10-Q · filed 2024-08-09 | |
| 2022-05-29 | $0.00 10-K · filed 2024-08-26 | |
| 2022-02-27 | $0.00 10-K · filed 2024-03-20 | |
| 2021-11-28 | $0.00 10-K · filed 2024-03-20 | |
| 2021-08-29 | $0.00 10-K · filed 2024-03-20 | |
| 2021-05-30 | $0.00 10-K · filed 2024-08-26 | |
| 2021-02-28 | $0.00 10-K · filed 2024-03-20 | |
| 2020-11-29 | $0.00 10-K · filed 2024-03-20 | |
| 2020-08-30 | $0.00 10-K · filed 2024-03-20 | |
| 2020-05-31 | $0.00 10-K · filed 2024-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |